ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q2SCImago #11,173Hybrid

Regenerative Engineering and Translational Medicine

Acronym:retm
•
Identifier (ISSN):2364-4133(Print)/2364-4141(Online)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
3.1↑ +1.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Regenerative Engineering and Translational Medicine

WoS Q2
12342.620232.220241.920253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q2
0.533
#11,173

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
31

31 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate4.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
47articles/year
13.72% Gold OA•61.7% Original Research

Aims & Scope

Regenerative Engineering is an international journal covering convergence of the disciplines of tissue engineering, advanced materials science, stem cell research, the physical sciences, and areas of developmental biology. This convergence brings exciting opportunities to translate bench-top research into bedside methods, allowing the possibility of moving beyond maintaining or repairing tissues to regenerating them. The journal encourages both top-down engineering approaches and bottom-up strategies integrating materials science with stem cell research and developmental biology. Convergence papers on instructive biomaterials, stimuli-responsive biomaterials, micro- and nano-patterning for regenerative engineering, elastomeric biomaterials, hydrogels for tissue engineering, and rapid prototyping and bioprinting approaches are particularly welcome. The journal provides a premier, single-blind peer-reviewed forum for the publication of original papers, authoritative reviews, rapid communications, news and views, and opinion papers addressing the most important issues and efforts toward successfully regenerating complex human tissues and organs. All research articles feature a lay abstract highlighting the relevance and future impact for patients, government and other health officials, and members of the general public. Bridging the gap between the lab and the clinic, the journal also serves as a dedicated platform for showcasing translational research that brings basic scientific research and discoveries into clinical methods and therapies, contributing to the improvement of human health care. Topics covered in Regenerative Engineering and Translational Medicine include: Advanced materials science for regenerative and biomedical applicationsStem cells for tissue regenerationDrug delivery for tissue regenerationNanomaterials and nanobiotechnology for tissue regenerationStudies combining tissue engineering/regeneration with developmental biologyConvergence research in pre-clinical and clinical phases

Topics Covered (Recognized by AI)
Biology83.9%Medicine80.7%Genetics75.4%Chemistry75%Biochemistry60%Cell biology53.6%Engineering50.7%Materials science42.9%Pathology40.7%Internal medicine40.4%Organic chemistry38.2%Biomedical engineering37.9%Physics31.1%Stem cell30.4%Cell29.6%Composite material26.4%Tissue engineering26.1%Computer science25.7%Surgery24.6%Immunology24.6%Nanotechnology23.9%Anatomy23.6%Chemical engineering22.1%In vitro22.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ENGINEERING, BIOMEDICAL

Q2
Rank64/130
IndexESCI
JCIESCI2026

ENGINEERING, BIOMEDICAL

Q4
Rank102/130
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.1
Articles / Year93
Total Citations19
2025
IF1.9
Articles / Year150
Total Citations300
2024
IF2.2
Articles / Year44
Total Citations330
2023
IF2.6
Articles / Year39
Total Citations221
2022
IF—
Articles / Year50
Total Citations460

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,173Scopus Q2SCImago Profile
Scopus Coverage:2015-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyEngineeringMaterials ScienceMedicine
Scopus Citation Rank (SJR)Q2
0.533

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.35

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,939 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations418
3-Year Documents136
Citable Documents134

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate42.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
BiomaterialsQ3
Biomedical EngineeringQ3
Cell BiologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENGINEERING, BIOMEDICAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Regenerative Engineering and Translational Medicine (acronym: retm, ISSN: 2364-4133) is a peer-reviewed international scholarly journal in the field of ENGINEERING, published by Springer Nature in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 0.533 (Q2), an H-index of 31.

The journal enforces rigorous peer evaluation with a publication frequency of 4 issues per year, an annual output of approximately 47 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,939 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
4 issues per year
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e4c87a7a-799b-4ce7-bd79-01025f5c24f9
Database Updated: 2026-09-29